Страна: Велика Британія
мова: англійська
Джерело: MHRA (Medicines & Healthcare Products Regulatory Agency)
Pericyazine
J M McGill Ltd
N05AC01
Pericyazine
2.5mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 04020100
-1- PACKAGE LEAFLET: INFORMATION FOR THE PATIENT PERICYAZINE 2.5MG TABLETS READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS INFORMATION IMPORTANT FOR YOU. • Keep this leaflet. You may need to read it again • If you have any further questions, ask your doctor or pharmacist • This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. What pericyazine is and what it is used for 2. What you need to know before you take pericyazine 3. How to take pericyazine 4. Possible side effects 5. How to store pericyazine 6. Contents of the pack and other information 1. WHAT PERICYAZINE IS AND WHAT IT IS USED FOR The name of your medicine is Pericyazine 2.5mg Tablets (referred to as pericyazine throughout this leaflet).This belongs to a group of medicines called ‘phenothiazines’. It works by blocking the effect of a chemical in the brain. It can be used for: • Schizophrenia • The short term treatment of anxiety, agitation and violent or dangerously impulsive behaviour when used with other medicines 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE PERICYAZINE DO NOT TAKE THIS MEDICINE AND TELL YOUR DOCTOR IF: ±You are allergic (hypersensitive) to pericyazine or any of the other ingredients in this medicine (listed in Section 6) ±Signs of an allergic reaction include: a rash, swallowing or breathing problems, swelling of your lips, face, throat or tongue ±You are pregnant, might become pregnant or think you may be pregnant (see Section below: ‘Pregnancy and breast-feeding’) Do not take this medicine if any of the above apply to you. If you are not sure, talk to your doctor or pharmacist before taking pericyazine. WARNINGS AND PRECAUTIONS TALK TO YOUR DOCTOR OR PHARMACIST BEFORE YOU TAKE THIS MEDICINE IF: SYou hav Прочитайте повний документ
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Pericyazine 2.5mg Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 2.5mg pericyazine. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Pericyazine 2.5mg Tablets: Circular, very pale lime-yellow tablet, with one face impressed ‘S171’ just inside the perimeter. Break-line on reverse. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS a) In adults with schizophrenia or other psychoses, for the treatment of symptoms or prevention of relapse. b) In anxiety, psychomotor agitation, violent or dangerously impulsive behaviour. Pericyazine is used as an adjunct to the short-term management of these conditions. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology _ Severe conditions _ _Indication (a) _ _ _ Adults:_ _Initially 75 mg per day in divided doses. Dosage should be increased by 25 mg per day at weekly intervals until the optimum effect is achieved. Maintenance therapy would not normally be expected to exceed 300 mg per day. Elderly: _ _Initially 15-30 mg per day in divided doses. If this is well tolerated the dosage may be increased if necessary for optimum control of behaviour. _Mild or moderate conditions _ _ _ _Indication (b) _ _ _ Adults: Initially 15-30 mg daily, divided into two portions with a larger dose being given in the evening. Elderly: 5-10 mg per day is suggested as a starting dose. It may be divided so that a larger portion is given in the evening. Half or quarter the normal adult dose may be sufficient for maintenance therapy. Pericyazine tablets are not recommended for children. Method of administration Oral. Dosage requirement varies with the individual and the severity of the condition being treated. Initial dosage should be low with progressive increases until the desired response is obtained, after which dosage should be adjusted to maintain control of the symptoms. 4.3 CONTRAINDICATIONS See use in pregnancy below. Known hypersensitivity to pericyazine or to any of the other excipi Прочитайте повний документ